Hero Image Patient Hero Image Patient Hero Image Patient
For on-demand treatment of acute hereditary angioedema (HAE) attacks
Be prepared for an HAE attack. Be prepared with BERINERT.
Rely on BERINERT at the first sign of an HAE attack for quick onset of relief

BERINERT is the only on-demand treatment offering:

15 min Icon

Fast onset relief from laryngeal attacks*

Fast onset relief from
laryngeal attacks*

Plus Sign
Icon C1 INH

Treating the root
cause of HAE attacks

Treating the root cause of
HAE attacks

Plus Sign
Icon Pediatrics

Approved use
in pediatrics

Approved use in pediatrics

More than 50% of people with HAE may experience a laryngeal attack in their lifetime1

If you self-administer to treat a laryngeal attack, immediately seek medical attention afterward.
*
Median time to onset symptom relief from a laryngeal attack was 15 minutes. Median time to complete resolution of symptoms was 8.4 hours.
BERINERT is the only C1-INH approved for on-demand treatment of acute abdominal, facial or laryngeal attacks of HAE in adults and pediatric patients.
Personalized support from the start
Provides ongoing, one-on-one support throughout your BERINERT journey.
Learn more
Reference: 1. Zuraw BL. Clinical practice: hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036.

You are now leaving the current website.

Do you want to continue?

No Yes